Transcatheter Aortic Valve Implantation: Bahrain Experience

Yousif, Nooraldaem; Subbramaniyam, Suddharsan; Thevan, Babu; Amin, Mohammad Al; Sulaibikh, Leena; Bukamal, Nazar; Tareif, Habib; Shivappa, Sadananda; Amin, Haitham; Noor, Husam A

doi:10.37616/2212-5043.1143

Cited by 3 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data also help contrast this single-centre experience from the UAE with published data elsewhere in the Gulf region ( Table 2 ). [ 6 , 7 ] Overall, annualised procedure volumes (per centre) and the average age of included patients are comparable across sites. Furthermore, patients undergoing TAVR in the Gulf region were generally younger than their counterparts treated at Q1 hospitals in the US, perhaps due to the difference in life expectancy between the two regions.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme

Edris¹,

Manla²,

Badarin³

et al. 2023

Interv Cardiol

View full text Add to dashboard Cite

Background: Data on outcomes of transcatheter aortic valve replacement (TAVR) in the Middle East, particularly in the United Arab Emirates (UAE), are limited. Whether centres with a low volume of patients requiring the procedure can achieve similar outcomes as those reported in pivotal clinical trials remains unclear. This study evaluates procedural outcomes of patients undergoing TAVR in a newly established programme in the UAE. Methods: Procedural outcomes of consecutive patients who underwent transfemoral TAVR at a single centre in the UAE between January 2016 and November 2021 were compared with those at centres in the lowest quartile (Q1) of procedural volume in the Transcatheter Valve Therapy Registry, which covers centres in the US. Results: Among the 183 patients included in the study, the median age was 76 years (interquartile range [IQR] 71–82), and 42.1% of patients were women, with a median Society of Thoracic Surgeons predicted risk of mortality score of 4.6 (IQR 2.9–7.5). Most of the patients (93.3%) received a balloon expandable valve. All-cause death within 30 days, stroke and major vascular complications occurred in 0.6%, 0.6% and 2.2% of patients, respectively, compared with 3.1%, 2.2% and 4% in patients treated at Q1 hospitals. Conclusion: Patients undergoing transfemoral TAVR at an emerging centre in the Middle East had favourable outcomes compared with those performed at Q1 hospitals in the US. These findings suggest that careful patient selection for TAVR is critical and may help optimise patient outcomes, especially when procedural volumes are low.

show abstract

Section: Discussionmentioning

confidence: 99%

Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme

Edris¹,

Manla²,

Badarin³

et al. 2023

Interv Cardiol

View full text Add to dashboard Cite

show abstract

Incidence, predictors, and clinical outcomes of permanent pacemaker insertion following transcatheter aortic valve implantation in an Arab population

Rajah

Alaamiri

Mahmoodurrahman

et al. 2021

J Interv Card Electrophysiol

View full text Add to dashboard Cite

Ethnic Disparities and Outcomes of Edwards Sapien Transcatheter Aortic Valve Implantation in Kuwait

Rajan

Jarallah

Dashti

et al. 2023

Annals of Clinical Cardiology

View full text Add to dashboard Cite

Introduction: Clinical outcomes after transcatheter aortic valve implantation (TAVI) have not been reported in the Gulf region. This study aims to identify baseline characteristics of patients undergoing TAVI, based on nationality, and analyze their overall outcomes at a single center in Kuwait. Methods: A retrospective study of 61 patients with severe aortic stenosis undergoing TAVI between 2018 and 2021 in Sabah Al Ahmad Cardiac Centre in Kuwait. Clinical and baseline demographics data along with preprocedural computed tomography (CT) and echocardiography were reviewed. Postprocedural outcomes, including conduction disturbances and inhospital mortality rates, were analyzed. Patients were analyzed according to Kuwaiti and non-Kuwaiti citizens' status. Results: The mean age of Kuwaiti patients was 72.2 ± 9.2, whereas the mean age of non-Kuwaiti citizens was 78.8 ± 5.5. No significant differences were observed between Kuwaiti and non-Kuwaiti in electrocardiogram (ECG) and CT parameters (P > 0.05). A statistically significant difference among Kuwaiti and non-Kuwaiti patients was observed only laboratory parameters, white blood cell (WBC) count, international normalized ratio (INR), and C-reactive protein (CRP). The mean value of WBC count (WBC), INR, and CRP was higher among non-Kuwaiti patients when compared to Kuwaiti patients (P < 0.05). Inhospital mortality was low 1/61 (1.6%). Conclusion: Cumulative inhospital mortality in TAVI was 1.6%. TAVI experience in Kuwait with Edwards SAPIEN valve is comparable to international cohorts. No significant differences in procedural outcomes, including conduction disturbance and mortality, were observed between the two subgroups.

show abstract

Transcatheter Aortic Valve Implantation: Bahrain Experience

Cited by 3 publications

References 20 publications

Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme

Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme

Incidence, predictors, and clinical outcomes of permanent pacemaker insertion following transcatheter aortic valve implantation in an Arab population

Ethnic Disparities and Outcomes of Edwards Sapien Transcatheter Aortic Valve Implantation in Kuwait

Contact Info

Product

Resources

About